This article has multiple issues. Please help improve it or discuss these issues on the talk page. ( Learn how and when to remove these template messages) This biography of a living person needs additional citations for verification. Please help by adding reliable sources. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libelous. Find sources:  "Jerry Avorn" –  news · newspapers · books · scholar · JSTOR (February 2017) ( Learn how and when to remove this template message) This biographical article is written like a résumé. Please help improve it by revising it to be neutral and encyclopedic. (February 2017) A major contributor to this article appears to have a close connection with its subject. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. Please discuss further on the talk page. (February 2017) ( Learn how and when to remove this template message) ( Learn how and when to remove this template message)

Jerry Avorn' (born February 13, 1948) is a professor of medicine at Harvard Medical School and Chief Emeritus of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. He founded one of the largest programs using health care utilization data to track medication use and outcomes, and invented the practice of " academic detailing" in which pharmacists, nurses, and physicians educate doctors about cost-effective prescribing practices using the same tactics that drug companies employ to market their products. He received a B.A. from Columbia University in 1969 and M.D. from Harvard Medical School in 1974.

Early life and education

Avorn was born in 1948, in New York City and grew up in Rockaway, Queens. While attending Columbia University during the opposition to the Vietnam War and American civil rights movement, he was a campus activist against the Vietnam War with his investigative journalism for the Columbia Daily Spectator. In the summer of 1969, he wrote Up Against the Ivy Wall with fellow Spectator journalists about the campus uprisings at Columbia.

Avorn graduated from Harvard Medical School with an M.D. in 1974. ^[1]

Career

Avorn was a resident at the Cambridge Hospital in Cambridge, Massachusetts and then at the Beth Israel Hospital (now the Beth Israel Deaconess Medical Center in Boston, Massachusetts). He became an associate professor at Harvard Medical School in 1985 and a full professor in 2005. [1]

In 1983, he published his first paper on academic detailing. The practice has been taken up by several hospitals and governments, such as Pennsylvania, Washington, DC, Kentucky, Australia, Israel, and Nova Scotia. His work on academic detailing was featured in The Wall Street Journal and on The Daily Show.

Avorn is also past president of the International Society for Pharmacoepidemiology.

In 2004, he founded Alosa Health, a nonprofit organization that develops and implements academic detailing programs to improve prescribing.

Avorn's group's paper on coxibs was one of the first medical research papers to demonstrate that Vioxx increased some patients' risk of heart attack and stroke.^{[ citation needed]} In 2006 he testified as a plaintiff’s expert witness in the Vioxx litigation, but he donated all profit from his involvement to charitable causes. He is one of the most highly cited authors in his field. [2]

Works

Avorn is the author of the 2004 book Powerful Medicines.

Notable research

• Avorn, Jerry; Soumerai, Stephen B. (1983). "A New Approach to Reducing Suboptimal Drug Use". JAMA. 250 (13): 1752–1753. doi: 10.1001/jama.1983.03340130070037. ISSN  0098-7484. PMID  6411945.
• Solomon, Daniel H.; Glynn, Robert J.; Levin, Raisa; Avorn, Jerry (2002). "Nonsteroidal Anti-inflammatory Drug Use and Acute Myocardial Infarction". Archives of Internal Medicine. 162 (10): 1099–1104. doi: 10.1001/archinte.162.10.1099. ISSN  0003-9926. PMID  12020178.
• Solomon, Daniel H.; Avorn, Jerry; Stürmer, Til; Glynn, Robert J.; Mogun, Helen; Schneeweiss, Sebastian (2006). "Cardiovascular Outcomes in New Users of Coxibs and Nonsteroidal Antiinflammatory Drugs". Arthritis & Rheumatism. 54 (5): 1378–1389. doi: 10.1002/art.21887. ISSN  0004-3591. PMID  16645966. ResearchGate: 7135233.

References

External links

• Official “Powerful Medicines” website
• Alosa Health
• Advertising: As Drug Bill Soars, Some Doctors Get An 'Unsales' Pitch
• Dr. Avorn on The Daily Show
• New York Times Op Ed "The Sting of Ignorance"